diverticulitis semaglutide With Diverticulitis: Safety and Key Cautions Digestive Health and GLP-1 Medications:

Lillys tirzepatide delivered up to 22.5% weight loss in adults with obesity or overweight in SURMOUNT-1

extended follow-up is necessary to clarify these dynamic trajectories

Dragonieri S, Portacci A, Quaranta VN, et al

Processed foods loaded with added sugars and refined oils should be swapped for whole-food alternatives that align with semaglutide's appetite-control benefits

Further scientific studies have identified GLP1 as a key player in the gut-brain regulatory axis, acting in the brain to dampen appetite-stimulating and food-related reward circuity, and in the periphery to heighten insulin secretion and sensitivity, reduce fat in the liver, and decrease gastric emptying and mobility